Citigroup initiates coverage on Brightpoint (Nasdaq: CELL) with a Hold. Price target $14.

Citigroup analyst, Daryl Armstrong ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE